Related Experiment Videos
Elf-1 binds to a critical element in a second CD4 enhancer
A L Wurster1, G Siu, J M Leiden
1Department of Biology and Cancer Center, University of California, San Diego, La Jolla 92093-0063.
Molecular and Cellular Biology
|October 1, 1994
Summary
Researchers identified a new CD4 gene enhancer crucial for T-cell development. This enhancer, active in mature T cells, is regulated by the Elf-1 transcription factor, advancing understanding of T-cell differentiation.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- T-cell development involves coordinated CD4 and CD8 expression, defining functional subclasses like CD4+ helper and CD8+ cytotoxic T cells.
- Understanding the molecular mechanisms regulating CD4 gene transcription is key to deciphering T-cell development and differentiation.
Purpose of the Study:
- To investigate the regulation of CD4 gene transcription during T-cell development.
- To identify novel regulatory elements involved in CD4 gene expression.
Main Methods:
- Identification and characterization of a novel transcriptional enhancer in the murine CD4 locus.
- Analysis of nuclear protein binding to the enhancer using T-cell nuclear extracts.
- Assessment of the role of specific transcription factor binding sites, particularly Ets consensus sites.
Main Results:
- A second transcriptional enhancer was identified in the murine CD4 locus, located 24 kb upstream of the CD4 promoter.
- This enhancer is active in mature T cells, with heightened activity in CD4+ helper T cells.
- Nuclear proteins, including transcription factors from the AP-1, Sp1, Gata, and Ets families, bind to the enhancer.
- The Ets consensus site is critical for enhancer activity, and Elf-1 was identified as a dominant binding protein at this site.
Conclusions:
- A novel CD4 gene enhancer plays a significant role in T-cell development and differentiation.
- The transcription factor Elf-1 is a key regulator of this enhancer's activity in T cells.
- These findings provide insights into the molecular control of CD4 expression and T-cell lineage commitment.